Third Rock Ventures II, L.P. Insider Trading $SAGE Sage Therapeutics, Inc.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Third Rock Ventures II, L.P..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Third Rock Ventures II, L.P.. Third Rock Ventures II, L.P. is 10% Owner in MyoKardia Inc ($MYOK) and 10% Owner in Blueprint Medicines Corp ($BPMC) and 10% Owner in Sage Therapeutics, Inc. ($SAGE) and 10% Owner in Allena Pharmaceuticals, Inc. ($ALNA) and 10% Owner in Global Blood Therapeutics, Inc. ($GBT) and 10% Owner in Jounce Therapeutics, Inc. ($JNCE) and 10% Owner in Revolution Medicines, Inc. ($RVMD).
Third Rock Ventures II, L.P. in Sage Therapeutics, Inc.
Trading Symbol: SAGEIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Third Rock Ventures II, L.P.: 10% Owner
Holdings: 2,892,916 shares
Current Value: $137,992,093
Latest Transaction: Aug 19 2016
$SAGE Market Capitalization: $1.75B
$SAGE Previous Close: $47.70
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Third Rock Ventures II, L.P. in Sage Therapeutics, Inc.
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, ALNA, BPMC, GBT, JNCE, MYOK, RVMD, SAGE
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Aug 19 2016 | SAGE | Sage Therapeutics, ... | Third Rock Ventures II, L.P. | 10% Owner | Sell | J | 0.00 | 1,000,000 | 0 | 2,892,916 | 3.9 M to 2.9 M (-25.69 %) |
May 18 2016 | SAGE | Sage Therapeutics, ... | Third Rock Ventures II, L.P. | 10% Owner | Sell | S | 31.25 | 850,000 | 26,562,500 | 3,892,916 | 4.7 M to 3.9 M (-17.92 %) |
Nov 13 2015 | SAGE | Sage Therapeutics, ... | Third Rock Ventures II, L.P. | 10% Owner | Buy | J | 0.00 | 15,986 | 0 | 65,227 | 49.2 K to 65.2 K (+32.46 %) |
Nov 13 2015 | SAGE | Sage Therapeutics, ... | Third Rock Ventures II, L.P. | 10% Owner | Buy | J | 0.00 | 15,986 | 0 | 65,226 | 49.2 K to 65.2 K (+32.47 %) |
Nov 13 2015 | SAGE | Sage Therapeutics, ... | Third Rock Ventures II, L.P. | 10% Owner | Sell | J | 0.00 | 109,832 | 0 | 0 | 109.8 K to 0 (-100.00 %) |
Nov 13 2015 | SAGE | Sage Therapeutics, ... | Third Rock Ventures II, L.P. | 10% Owner | Buy | J | 0.00 | 109,832 | 0 | 109,832 | 0 to 109.8 K |
Nov 13 2015 | SAGE | Sage Therapeutics, ... | Third Rock Ventures II, L.P. | 10% Owner | Sell | J | 0.00 | 1,700,000 | 0 | 4,742,916 | 6.4 M to 4.7 M (-26.39 %) |
Aug 18 2015 | SAGE | Sage Therapeutics, ... | Third Rock Ventures II, L.P. | 10% Owner | Buy | J | 0.00 | 21,910 | 0 | 49,241 | 27.3 K to 49.2 K (+80.17 %) |
Aug 18 2015 | SAGE | Sage Therapeutics, ... | Third Rock Ventures II, L.P. | 10% Owner | Buy | J | 0.00 | 21,910 | 0 | 49,240 | 27.3 K to 49.2 K (+80.17 %) |
Aug 18 2015 | SAGE | Sage Therapeutics, ... | Third Rock Ventures II, L.P. | 10% Owner | Sell | J | 0.00 | 150,546 | 0 | 0 | 150.5 K to 0 (-100.00 %) |
Aug 18 2015 | SAGE | Sage Therapeutics, ... | Third Rock Ventures II, L.P. | 10% Owner | Buy | J | 0.00 | 150,546 | 0 | 150,546 | 0 to 150.5 K |
Aug 18 2015 | SAGE | Sage Therapeutics, ... | Third Rock Ventures II, L.P. | 10% Owner | Sell | J | 0.00 | 2,330,157 | 0 | 6,442,916 | 8.8 M to 6.4 M (-26.56 %) |
Jun 22 2015 | SAGE | Sage Therapeutics, ... | Third Rock Ventures II, L.P. | 10% Owner | Buy | J | 0.00 | 9,403 | 0 | 27,331 | 17.9 K to 27.3 K (+52.45 %) |
Jun 22 2015 | SAGE | Sage Therapeutics, ... | Third Rock Ventures II, L.P. | 10% Owner | Buy | J | 0.00 | 9,402 | 0 | 27,330 | 17.9 K to 27.3 K (+52.44 %) |
Jun 22 2015 | SAGE | Sage Therapeutics, ... | Third Rock Ventures II, L.P. | 10% Owner | Sell | J | 0.00 | 64,607 | 0 | 0 | 64.6 K to 0 (-100.00 %) |
Jun 22 2015 | SAGE | Sage Therapeutics, ... | Third Rock Ventures II, L.P. | 10% Owner | Buy | J | 0.00 | 64,607 | 0 | 64,607 | 0 to 64.6 K |
Jun 22 2015 | SAGE | Sage Therapeutics, ... | Third Rock Ventures II, L.P. | 10% Owner | Sell | J | 0.00 | 1,000,000 | 0 | 8,773,073 | 9.8 M to 8.8 M (-10.23 %) |
Jul 23 2014 | SAGE | Sage Therapeutics, ... | Third Rock Ventures II, L.P. | 10% Owner | Option Exercise | C | 0.00 | 295,194 | 0 | 0 | |
Jul 23 2014 | SAGE | Sage Therapeutics, ... | Third Rock Ventures II, L.P. | 10% Owner | Option Exercise | C | 0.00 | 2,499,999 | 0 | 0 | |
Jul 23 2014 | SAGE | Sage Therapeutics, ... | Third Rock Ventures II, L.P. | 10% Owner | Option Exercise | C | 0.00 | 32,500,000 | 0 | 0 | |
Jul 23 2014 | SAGE | Sage Therapeutics, ... | Third Rock Ventures II, L.P. | 10% Owner | Buy | C | 0.00 | 93,712 | 0 | 11,681,008 | 11.6 M to 11.7 M (+0.81 %) |
Jul 23 2014 | SAGE | Sage Therapeutics, ... | Third Rock Ventures II, L.P. | 10% Owner | Buy | C | 0.00 | 793,650 | 0 | 11,587,296 | 10.8 M to 11.6 M (+7.35 %) |
Jul 23 2014 | SAGE | Sage Therapeutics, ... | Third Rock Ventures II, L.P. | 10% Owner | Buy | C | 0.00 | 10,317,457 | 0 | 10,793,646 | 476.2 K to 10.8 M (+2,166.67 %) |
Page: 1